Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by DIGGORY, P.
Right arrow Articles by FRANKS, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DIGGORY, P.
Right arrow Articles by FRANKS, W. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1997 Oxford University Press

book-review

Glaucoma therapy may take your breath away

PAUL DIGGORY and WENDY A. FRANKS1

Department of Elderly Care Medicine, Mayday Hospital Mayday Road, Croydon CR7 7YE, UK
1Consultant in Ophthalmology, Glaucoma Unit Moorfields Eye Hospital City Road, London ECIV 2PD, UK

Address correspondence to: P. Diggory. Fax; (+44) 171 828 2564

Chronic simple glaucoma is a common disease in old age and lowering intraocular pressure is the treatment strategy. Although this can be achieved surgically, medical treatment with eye drops is more often prescribed. ß-antagonists are the class of drug most often chosen, although other medical therapies are available. Systemic absorption of ß-antagonist eye drops can cause unsuspected respiratory impairment. Physicians should be alert to the possibility of respiratory side-effects of topical therapy with ß-antagonists and whenever such side-effects occur should use alternative treatments.

Keywords: ß-antagonists, glaucoma, respiratory impairment

Received October 10, 1996;
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch OphthalmolHome page
S.-Y. Wu, B. Nemesure, A. Hennis, A. P. Schachat, L. Hyman, M. C. Leske, and for the Barbados Eye Studies Group
Open-angle Glaucoma and Mortality: The Barbados Eye Studies
Arch Ophthalmol, March 1, 2008; 126(3): 365 - 370.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
The Eye Diseases Prevalence Research Group
Prevalence of Open-Angle Glaucoma Among Adults in the United States
Arch Ophthalmol, April 1, 2004; 122(4): 532 - 538.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
P. Nelson, P. Aspinall, and C. O'Brien
Patients' perception of visual impairment in glaucoma: a pilot study
Br. J. Ophthalmol., May 1, 1999; 83(5): 546 - 552.
[Abstract] [Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.